Comparing the current results to its competitors, Surgalign Holdings Inc reported Revenue decrease in the 1 quarter 2023 year on year by -18.72 %, despite the revenue increase by the most of its competitors of 8.17 %, recorded in the same quarter.
Surgalign Holdings Inc Net Income in the 1 quarter 2023 grew year on year by 15251.85%, while most of its competitors have experienced a contraction in net income by -72.99 %.
Medtronic Plc operates a global business model centered on the development and distribution of advanced medical technologies across four key segments: Cardiac and Vascular, Minimally Invasive Therapies, Restorative Therapies, and Diabetes. The company emphasizes innovation and collaboration with healthcare providers to enhance patient outcomes and drive efficiency within healthcare systems.
Medinotec Inc is a medical technology company that operates on a business model focused on developing and providing innovative healthcare solutions, such as medical devices and software, to improve patient care and outcomes. Their products and services cater to healthcare professionals and institutions, offering advanced technology solutions in the medical field.
Orthopediatrics Corp is a medical device company specializing in orthopedic implants and instruments for children with orthopedic conditions. Their business model revolves around designing, manufacturing, and distributing innovative pediatric orthopedic products to healthcare providers worldwide. By focusing solely on pediatric patients, they aim to address the unique needs and challenges in this niche market, providing quality solutions for improved pediatric orthopedic care.
Johnson & Johnson operates as a multinational healthcare company with a diversified business model that spans pharmaceuticals, medical devices, and consumer health products. By focusing on innovation and strategic acquisitions, the company aims to improve global health and well-being.
Sources:
Surgalign Holdings Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Surgalign Holdings Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
